2013 | Partial Virological Response to Adefovir Add-On Lamivudine Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B | DIGESTION |
2011 | Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B. | ANTIVIRAL THERAPY |
2021 | Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study | DIGESTIVE DISEASES AND SCIENCES |
2012 | Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis
| PLOS ONE |
2008 | Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection | LIVER INTERNATIONAL |
2021 | Pharmacokinetics and safety of evogliptin in hepatically impaired patients | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
2019 | Phase I/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma | DIGESTIVE AND LIVER DISEASE |
2007 | PIVKA-II Is a Useful Tumor Marker for Recurrent Hepatocellular Carcinoma after Surgical Resection | ONCOLOGY |
2019 | Postoperative Recurrence of Hepatocellular Carcinoma: The Importance of Distinguishing between Intrahepatic Metastasis and Multicentric Occurrence-Response | CLINICAL CANCER RESEARCH |
2016 | Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response.
| GUT AND LIVER |
2014 | Prediction of development of liver-related events by transient elastography in Hepatitis B patients with complete virological response on antiviral therapy | AMERICAN JOURNAL OF GASTROENTEROLOGY |
2012 | Prediction of esophageal variceal bleeding in B-viral liver cirrhosis using the P2/MS noninvasive index based on complete blood counts. | DIGESTION |
2012 | Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis
| PLOS ONE |
2008 | Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan((R))) before curative resection of hepatocellular carcinoma: a pilot study
| HEPATOLOGY INTERNATIONAL |
2012 | Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan®) | ANNALS OF SURGICAL ONCOLOGY |
2011 | Prediction of significant fibrosis in chronic hepatitis C patients with normal ALT | HEPATO-GASTROENTEROLOGY |
2016 | Prediction of virologic response to tenofovir mono-rescue therapy for multidrug resistant chronic hepatitis B | JOURNAL OF MEDICAL VIROLOGY |
2023 | Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment
| CANCER MEDICINE |
2011 | Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma | LIVER INTERNATIONAL |
2022 | Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis B | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2019 | Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy
| SCIENTIFIC REPORTS |
2012 | Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers | LIVER INTERNATIONAL |
2021 | Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization
| CURRENT ONCOLOGY |
2019 | Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis
| JOURNAL OF CLINICAL MEDICINE |
2018 | Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2013 | Predictors of Refractory Ascites Development in Patients with Hepatitis B Virus-Related Cirrhosis Hospitalized to Control Ascitic Decompensation
| YONSEI MEDICAL JOURNAL |
2022 | Predictors of Sarcopenia in an Obese Asian Population | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL |
2008 | Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study. | LIVER INTERNATIONAL |
2017 | Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease | DIGESTIVE DISEASES AND SCIENCES |
2022 | Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B | DIGESTIVE DISEASES AND SCIENCES |
2020 | Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
| INTESTINAL RESEARCH |
2020 | Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation
| CANCERS |
2014 | Prognosis of hepatocellular carcinoma patients with extrahepatic metastasis and the controllability of intrahepatic lesions | CLINICAL & EXPERIMENTAL METASTASIS |
2019 | Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
2011 | Prognostic factors and 10-year survival in patients with hepatocellular carcinoma after curative hepatectomy | JOURNAL OF GASTROINTESTINAL SURGERY |
2017 | Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolization | HEPATOLOGY INTERNATIONAL |
2014 | Prognostic Indicators for Acute Liver Failure Development and Mortality in Patients with Hepatitis A: Consecutive Case Analysis
| YONSEI MEDICAL JOURNAL |
2015 | Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization | LIVER INTERNATIONAL |
2016 | Prognostic Significance of ¹?F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study
| JOURNAL OF NUCLEAR MEDICINE |
2011 | Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib | LIVER INTERNATIONAL |
2021 | Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2017 | Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma | CLINICAL NUCLEAR MEDICINE |
2013 | Prognostic Value of Model for End-Stage Liver Disease Scores in Patients with Fulminant Hepatic Failure | TRANSPLANTATION PROCEEDINGS |
2011 | Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. | EUROPEAN JOURNAL OF CANCER |
2015 | Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B | LIVER INTERNATIONAL |
2013 | Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
| BMC CANCER |
2019 | Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive Infection | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study
| GUT AND LIVER |
2012 | Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B
| PLOS ONE |
2012 | Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B
| PLOS ONE |
2010 | Prospective validation of P2/MS noninvasive index using complete blood counts for detecting oesophageal varices in B-viral cirrhosis | LIVER INTERNATIONAL |
2013 | Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma
| CANCER RESEARCH |
2011 | Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir. | HEPATOLOGY |
2013 | Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
| GUT AND LIVER |
2016 | Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis
| PLOS ONE |
2015 | Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: A Multicenter Prospective Study | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
2012 | Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2019 | Radiomics on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma
| CLINICAL CANCER RESEARCH |
2018 | Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2016 | Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data
| CANCER RESEARCH AND TREATMENT |